Clin2
NCT05494398Possibly a fitEnrolling by invitation

Testing N-acetylcysteine for autism symptoms

Autism Spectrum Disorder

Treatments studied

Part of Mental health clinical trials.

This study looks at whether N-acetylcysteine (NAC), a supplement/medication, can help autism-related symptoms by trying to target brain chemistry. You may be able to join if you previously took part in a related NAC study and can keep your usual medications steady.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
144 people
Ages
3 years to 13 years
Study type
Interventional

Who can take part

  • You previously took part in a related NAC study (either a single-dose study or a randomized controlled NAC study).
  • You must have a stable medication plan for at least 30 days.
  • You and your study team should not expect medication changes during this trial.
  • You should not have major other medical problems that could make participation unsafe or unstable.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05664789Recruiting· Phase 2/Phase 3
N-acetylcysteine for autism behaviors in children

This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.

Palo Alto, California
NCT04278898Recruiting· Phase 2
N-acetylcysteine to reduce repetitive behaviors in children with autism

This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.

Stanford, California
NCT06623227Enrolling by invitation
Antioxidant supplement study for children with autism

This study tests whether an antioxidant supplement (something that fights cell damage) can help children with autism. It lasts 3 months and requires that the child stays on their current treatments without changes.

Makassar, South Sulawesi
NCT07642661Recruiting· Phase 2
Folinic Acid for Autism in Young Children

This study tests whether folinic acid (a B-vitamin supplement) can help improve autism symptoms in children ages 3–6. Folinic acid may support brain function, and researchers want to see if it works better than placebo (a dummy pill).

Jerusalem, N/A = Not Applicable
NCT06477263Recruiting
Testing the NeuroCytotron device for autism spectrum disorder

This trial tests a device called the NeuroCytotron to see if it can help people with autism. It is for individuals aged 3 to 50 who have a confirmed autism diagnosis and are medically stable.

San Pedro Garza García, Nuevo León
NCT07630506Recruiting· Phase 2
Folinic Acid for Autism in Children Ages 3–10

This study tests whether folinic acid (a type of B vitamin) can help improve symptoms of autism in children. Researchers want to see if this supplement, combined with your child's current treatments, might make a difference.

Singapore, Singapore

Hear when a new Autism spectrum disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.